Image1 (Valganciclovir Image1)
Valganciclovir Tablet
Product Images NDC 27241-158
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 27241-158). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image2 (Valganciclovir Image2)
This text describes the Schwartz equation to estimate the creatinine clearance rate in mL/min/1.73m² based on the person's height in cm and serum creatinine level in mg/dL.*
Structure (Valganciclovir Structure)
Valganciclovir_450mg (Valganciclovir 450mg)
This is a description for a medication called Valganciclovir Hydrochloride. The tablet contains 496.3 mg of the medication, which is equivalent to 450 mg of Valganciclovir. The usual dosage is not provided and should be referred to the package insert. The package is child-resistant, and it should be stored between 20°C to 25°C (68°F to 77°F). Strict adherence to dosage recommendations is crucial to avoid overdose. The medication is marketed by Ajanta Pharma USA Inc. in Bridgewater, NJ 08807, and it's made in India. It's available in tight containers as defined in USP/NF. The code number is GUJDRUGS/G/25/2080, and the NDC is 27241-158-60, with 60 tablets. It's essential to dispense the accompanying Patient Information to each patient. Breaking or crushing the tablets is not allowed.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
